Prognostic molecular markers in oral and lip squamous cell carcinoma - Evaluation of expression and its significance;Ekspresja niektórych molekularnych markerów immunohistochemicznych i ocena ich znaczenia prognostycznego w rakach płaskonabłonkowych jamy ustnej i wargi

Otolaryngologia Polska

Volumn 62, Issue 2, 2008, Pages 175-181

  Jaworska, Magdalena ^a,c   Kołosza, Zofia ^a   Liszka, Joanna ^a   Nikiel, Barbara ^a   Goleń, Maria ^a   Lange, Dariusz ^a   Ścierski, Wojciech ^a   Namysłowski, Grzegorz ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c NONE   (Poland)

Author keywords

Cathepsin B; Cycline D1; Head and neck squamous cell carcinoma; Ki67; P53

Indexed keywords

EID: 44349125163     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0030-6657(08)70236-1     Document Type: Article

References (24)

1. Pukkila MJ, Kumpulainen EJ, Virtaniemi JA, Johanssom RT, Halonen PM, Kellokoski JK. Nuclear and cytoplasmic p53 expression in pharyngeal squamous cell cercinoma: prognostic implications. Head Neck 2002; 24(8): 784-791.
2. De Vincente JC, Gutierrez LM, Zapatero AH, Forcedello M.F, Hernandez-Vallejo G, Arranz JS. Prognostic significance of p53 expression in oral squamous cell carcionoma without neck node metastases. Head Neck 2004; 26: 22-30.
3. Andrews GA, Sichuan X, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL. Mutation of p53 in head and neck squamous cell carcinoma correlates with BCL-2 expression and increased susceptibility to cisplatin-induced apoptosis. Head Neck 2004; 26: 870-877.
4. Gallo O, Schivone N, Papucci L, Sardi I, Magnelli L, Franchi A. Down-Regulation of Nitric Oxide Synthase-2 and Cyclooxygenase-2 Pathways by p53 in Squamous Cell Carcinoma. Am J Pathol. 2003; 163: 723-732.
5. Capaccio P, Pruneri G, Carboni N, Pagliari AV, Quatela M, Cesana BM. Cyclin D1 Expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 2000; 22: 234-240.
6. Kawasaki G, Kato Y, Mizuno A. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93(4): 446-454.
7. Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller D, Zacharias W. Variable expression of Cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum Pathol 2000; 31 (8): 931-937.
8. Wickramasinghe NS, Nagaraj NS, Vigneswaran N, Zacharias W. Cathepsin B promotes both motility and invasivenes of oral carcinoma cells. Arch Biochem Biophys 2005; 436(1): 187-195.
9. Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 2001; 23(2): 147-159.
10. Hauser U, Balz V, Carey TE, Grenman R, Van Lierop A, Scheckenbach K, i wsp. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region. Head Neck 2002; 24(9): 868-873.
11. Bradford CR, Zhu S, Ogawa H, Ogawa T, Ubell M, Narayan A. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck 2003; 25(8): 654-661.
12. Chow V, Yuen AP, Lam KY, Ho WK, Wei WI. Prognostic significations of serum p53 protein and p53 antibody in patients with surgical treatment for the head and neck squamous cell carcinoma. Head Neck 2001; 23(4): 286-291.
13. Fiedman M, Lim JW, Manders E, Schaffner AD, Kirshenbaum GL, Tanyeri HM. Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck 2001; 23: 280-285.
14. Liu M, Lawson G, Delos M, Jamart J, Ide Ch, Coche E. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies, of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations. Head Neck 2003; 25: 280-288.
15. Almadori G, Galli J, Cadoni G, Bussu F, Maurizi M. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic funcion and clinical significance. Head Neck 2002; 24(6): 597-604.
16. Park SW, Lee SG, Song SH, Heo DS, Park BJ, Lee DW. The effect of nitric oxide on cycloxygenase-2 (COX-2) overexpresion in head and neck cancer cell lines. Int J Cancer 2003; 107(5): 729-738.
17. Ranelletti FO, Almandori G, Rocca B, Ferrandina G, Ciabattoni G, Habib A. Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. Int J Cancer 2001; 95: 343-349.
18. Lim SC, Park SY, Do NY. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma. Oncol Rep. 2003; 10(5): 1073-1079.
19. Tang DW, Lin SC, Chang KW, Chi CW, Chang CS, Liu TY. Elevated expression of cyclooxygenase (COX)-2 in oral squamous cell carcinoma-evidence of COX-2 induction by areca quid ingredients in oral kerationcytes. J Oral Pathol Med. 2003; 2(9): 522-529.
20. Amirghahari N, Harrson L, Smith M, Rong X, Naumann I, Ampil F. NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2. Int Radiat Oncol Biol Phys 2003; 57(5): 1405-1412.
21. Mestre JR, Chan G, Zhang F, Yang EK, Sacks PG, Boyle JO. Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer. Ann N Y Acad Sci 1999; 889: 62-71.
22. Nagai N, Tian X, Mukai K, Hirata E, Kusuda T, Shigemasa K. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemoteraphy. Int J Mol Med 2003; 12(5): 709-714.
23. Kawada A, Hara K, Kominami E, Kobayashi T, Hiruma M, Ishbashi A. Cathepsin B and D expression in squamous cell carcinoma. Br J Dermatol 1996; 135(6): 905-910.
24. Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell carcinoma. Anticanc Res 1998; 18(6B): 4793-4800.